Revolutionizing Glioblastoma Treatment: A Comprehensive Overview of Modern Therapeutic Approaches
International Journal of Molecular Sciences · 26.05.2024 · 25 (11) · 5774
DOI: 10.3390/ijms25115774 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.05.2024. Verfasst von Karol Sadowski und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Histology and Embryology, Medical University of Warsaw, Chalubinskiego 5, 02-004 Warsaw, Poland. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 215 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Glioblastoma is the most common malignant primary brain tumor in the adult population, with an average survival of 12.1 to 14.6 months. The standard treatment, combining surgery, radiotherapy, and chemotherapy, is not as efficient as we would like. However, the current possibilities are no longer limited to the standard therapies due to rapid advancements in biotechnology. New methods enable a more precise approach by targeting individual cells and antigens to overcome cancer. For the treatment of glioblastoma, these are gamma knife therapy, proton beam therapy, tumor-treating fields, EGFR and VEGF inhibitors, multiple RTKs inhibitors, and PI3K pathway inhibitors. In addition, the increasing understanding of the role of the immune system in tumorigenesis and the ability to identify tumor-specific antigens helped to develop immunotherapies targeting GBM and immune cells, including CAR-T, CAR-NK cells, dendritic cells, and immune checkpoint inhibitors. Each of the described methods has its advantages and disadvantages and faces problems, such as the inefficient crossing of the blood–brain barrier, various neurological and systemic side effects, and the escape mechanism of the tumor. This work aims to present the current modern treatments of glioblastoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Department of Histology and Embryology, Medical University of Warsaw, Chalubinskiego 5, 02-004 Warsaw, Poland.
- Department of Biochemistry and Pharmacogenomics, Faculty of Pharmacy, Medical University of Warsaw, 02-091 Warsaw, Poland.
- Centre for Preclinical Research, Medical University of Warsaw, 02-091 Warsaw, Poland.
- The Department of Anatomy and Neurobiology, Medical University of Gdansk, Dębinki 1, 80-211 Gdansk, Poland.
- Department of Radiology I, The Maria Sklodowska-Curie National Research Institute of Oncology, Roentgena 5, 02-781 Warsaw, Poland.
ORCID-Profile: Adrianna Jażdżewska, Aleksandra Zacny, Tomasz Lorenc, Wioletta Olejarz
Zitieren
APA
Sadowski, K., Jażdżewska, A., Kozłowski, J., Zacny, A., Lorenc, T., & Olejarz, W. (2024). Revolutionizing Glioblastoma Treatment: A Comprehensive Overview of Modern Therapeutic Approaches. International Journal of Molecular Sciences, 25(11), 5774. https://doi.org/10.3390/ijms25115774
Vancouver
Sadowski K, Jażdżewska A, Kozłowski J, Zacny A, Lorenc T, Olejarz W. Revolutionizing Glioblastoma Treatment: A Comprehensive Overview of Modern Therapeutic Approaches. International Journal of Molecular Sciences. 2024;25(11):5774. doi:10.3390/ijms25115774
BibTeX
@article{Sadowski2024,
author = {Sadowski, Karol and Jażdżewska, Adrianna and Kozłowski, Jan and Zacny, Aleksandra and Lorenc, Tomasz and Olejarz, Wioletta},
title = {Revolutionizing Glioblastoma Treatment: A Comprehensive Overview of Modern Therapeutic Approaches},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {11},
pages = {5774},
doi = {10.3390/ijms25115774}
}
EUVIMED